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K e y  M e s s a g e s 
1. Anti-SARS-CoV spike antibodies promote 
infection of primary human immune cells by 
SARS-CoV. 
2. The antibody-dependent enhancement 
(ADE) infection pathway grants SARS-CoV 
an opportunity to infect primary human 
macrophages, but it does not sustain productive 
viral replication in the infected cells.
3. ADE of SARS-CoV infection does not alter pro-
inflammatory gene expression profile of primary 
human macrophages.
4. Infectivity of SARS-CoV does not rely solely 
on the potency of target cells to bind - via 
Fcγ receptor II (CD32) - infectious immune 
complexes, but depends on the properties of the 
intracellular domain of the FcγRII.
5. Occurrence of ADE of SARS-CoV infection into 
Antibody-dependent enhancement of SARS 
coronavirus infection and its role in the 
pathogenesis of SARS
MS Yip, HL Leung, PH Li, CY Cheung, I Dutry, D Li, M Daëron, R Bruzzone, JSM Peiris, M Jaume *
Introduction
Infection with SARS-CoV involves not only the 
respiratory tract but also the gastrointestinal tract 
and other organ systems. Several reports have 
highlighted the direct infection of haematopoietic 
cells by SARS-CoV. It is unclear how the virus gets 
into immune cells that do not express the SARS-CoV 
receptor angiotensin I converting enzyme 2 (ACE2).
 Immune-mediated infections and, in particular, 
antibody-dependent enhancement (ADE) is known 
to be exploited by a variety of viruses, such as dengue 
virus, HIV, and animal coronavirus, as an alternative 
way to infect host cells.1 In addition to an interaction 
between viral protein and host receptors, these 
viruses can enter cells through the binding of virus/
antibody immune-complexes to Fc receptors (FcR), 
complement receptors, or alternatively by inducing 
conformational change in envelope glycoproteins 
that are required for virus-cell membrane fusion.1
 We have demonstrated that anti-spike 
antibodies potentiate infection of both monocytic 
and lymphoid human immune cell lines with 
SARS-CoV Spike-pseudotyped lentiviral particles 
(recombinant viruses encoding a reporter gene 
and bearing SARS-CoV Spike proteins at the virion 
surface; SARS-CoVpp) and also with replication-
competent SARS-coronavirus.2 Because antibody-
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mediated infection accounts for the altered 
response to infection, we hypothesised that ADE 
of SARS-CoV infection—by widening SARS-CoV 
tropism toward immune cells—would elicit a hyper-
induced profile of immune mediators (cytokine/
chemokines) that would impair the homeostasis of 
the immune system and ultimately contribute to 
SARS pathogenesis.
 This study highlighted the occurrence of ADE 
of SARS-CoVpp infection in different circulating 
immune cell types, among which the monocytic 
lineage was a prime target. In addition to monocytes, 
infection of human macrophages was enhanced in 
the presence of anti-viral antibodies. Despite being 
increasingly susceptible to infection, macrophages 
did not support productive replication of the virus, 
or modify expression of some pro-inflammatory 
cytokines/chemokines upon antibody-mediated 
invasion. Our findings point towards the likely 
occurrence of ADE infection of immune cells by 
SARS-CoV, but the outcomes of such an alternative 
infection pathway on the cell functionality/
homeostasis remain unclear.
Methods
This study was conducted from October 2009 to 
September 2011. 
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES
human primary macrophages, without alteration 
to their pro-inflammatory properties, advocates 
cautious development of SARS-CoV vaccine in 
humans, and provides new ways of investigation 
to understand the pathogenesis of SARS.
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Cell lines and primary human immune cell 
cultures
VeroE6 (African green monkey kidney epithelial 
cells), Raji (Burkitt’s lymphoma/B lymphoblast), 
parental ST486 (Burkitt’s lymphoma/B lymphoblast 
lacking expression of FcγR) and FcγR/ST486 were 
cultured as previously described.2
 Peripheral blood mononuclear cells (PBMCs) 
were prepared from human buffy coats of healthy 
blood donors (Hong Kong Red Cross Blood 
Transfusion Service). The research protocol was 
approved by the Institutional Review Board of the 
University of Hong Kong/Hospital Authority Hong 
Kong West Cluster (UW09-375). Monocyte-derived 
macrophages were generated in vitro using standard 
protocol. Briefly, mononuclear cells were isolated by 
a Ficoll-Paque density gradient (Pharmacia Biotech) 
and monocytes were enriched by plastic adherence. 
Alternatively, CD14+ purified monocluclear cells 
were prepared by positive magnetic bead selection 
(Miltenyi biotec). Cells were then seeded on tissue 
culture plates in RPMI 1640 medium supplemented 
with 5% heat-inactivated autologous plasma, 0.6 mg/L 
penicillin and 60 mg/L streptomycin at 106 cells/mL 
(Life Technologies). The cells were replenished 
with fresh medium every 2 days and allowed to 
differentiate for 14 days. The purity of macrophages 
was consistently above 90%, as ascertained by 
immunofluorescence staining for human CD68 
(macrosialin/gp110). Depending on the downstream 
application, macrophages were either seeded on a 
glass-cover slip or in an appropriate culture vessel 
the day before infection. All cells were maintained 
in a humidified atmosphere at 37ºC with 5% CO2 
supply.
Immunisation with recombinant spike 
proteins or inactivated SARS-CoV
Recombinant SARS-CoV spike protein production 
and immunisation procedure have been described.2 
Six- to 8-week-old BALB/c mice (n=4-5 per group) 
were immunised intraperitoneally at 3-week intervals 
with 2 µg of FLAG-tagged recombinant codon-
optimised SARS-CoV spike full-length or injected 
with saline solution emulsified with 1 mg of alum. 
Sera were collected at day 55 post-immunisation, 
heat-inactivated for 30 minutes at 56ºC and stored at 
-20ºC for subsequent use.
Production and use of lentiviral pseudotyped 
particles
The pseudotyped viral particles expressing 
a luciferase reporter gene were produced as 
described.2 Briefly, SARS-CoV spike pseudotyped 
lentiviral particles (SARS-CoVpp), vesicular 
stomatitis virus glycoprotein pseudotyped lentiviral 
particles (VSVpp) or lentiviral particles lacking 
expression of any viral envelope protein (Δenv.pp) 
were obtained by transfection of HEK293T cells 
with an HIV-1 provirus construction (pNL4.3.Luc 
R−E−pro−) and a plasmid encoding the viral envelope 
protein of interest, ie SARS-CoV spike, VSV-G, or 
empty vector (pcDNA3.1; Invitrogen), respectively. 
Following a purification step on 20% sucrose cushion, 
the concentrated viral particles were titrated by 
ELISA for lentivirus-associated HIV-1 p24 protein 
according to the manufacturer’s instructions (Cell 
Biolabs) and the viral stocks were stored at -80ºC 
until use.
Infection with SARS-CoV
Serial, 2-fold dilutions of heat-inactivated mouse 
serum were incubated for 1 hour at 37ºC with an 
equal volume of live SARS-CoV (strain HKU-39849) 
under appropriate containment in a BSL3 laboratory 
(Department of Microbiology, The University of 
Hong Kong). Cells were infected at a multiplicity of 
infection (MOI) of 1 for 60 minutes at 37ºC, washed 
and then incubated in supplemented culture medium 
containing appropriate dilutions of mouse serum. 
At the end of the experiment cells were either fixed 
in 4% paraformaldehyde (dissolved in phosphate-
buffered saline) for immunofluorescence microscopy, 
or resuspended in lysis buffer (RLT buffer, RNeasy 
RNA Mini kit; QIAGEN) for real-time quantitative 
PCR and stored appropriately until use. Additionally, 
samples of cell culture supernatants (100 μL) 
harvested at different time points were mixed with 
350 μL of RLT buffer and stored at -80ºC until use.
Immunofluorescence microscopy
To assess SARS-CoV infection, cells were incubated 
for 45 minutes with a mouse monoclonal antibody 
specific for the viral nucleoprotein (N), and revealed 
by secondary TRITC-conjugated goat anti-mouse 
(Zymed Laboratories). To assess SARS-CoV Spike 
pseudoparticle (SARS-CoVpp) infection, cells were 
incubated for 45 minutes with FITC-conjugated 
polyclonal goat anti FireFly luciferase (Rockland). 
Slides were assembled with DAPI-containing 
mounting reagent (Southern Biotech) and analysed 
with an AxioObserver Z1 microscope (Zeiss). 
Pictures from 5-10 randomly selected fields were 
acquired with an Axiocam MRm camera and 
processed with MetaMorph software (Molecular 
Devices).
Real-time quantitative RT-PCR for viral gene 
expression
Total RNAs were extracted with an RNeasy 
RNA Mini kit (QIAGEN), with DNase digestion, 
according to the manufacturer’s instructions. 
Extracted RNAs were stored at -80ºC until use. 
Superscript III reverse transcriptase (Invitrogen) 
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and random hexamer primers (Invitrogen) or gene-
specific oligonucleotides were used to convert RNAs 
to cDNAs. The amount of viral and host RNA was 
measured by real-time quantitative PCR using 
SybrGreen-based technology on a LightCycler 480-II 
instrument (Roche).
Statistical analysis
Differences between groups were compared using 
the unpaired Student’s t-test with a 0.05 significance 
level.
Results
Anti-spike immune serum promotes 
infection of primary human immune cells 
with SARS-CoV
Following previous observations made with human 
immune cell lines,2 we determined whether ADE of 
SARS-CoV infection could occur also in primary 
human immune cells. To explore this hypothesis, we 
pre-incubated SARS-CoVpp with mouse anti-spike 
control serum prior to infection of PBMCs. We then 
examined the extent of infection by monitoring the 
expression of the luciferase reporter protein encoded 
by the SARS-CoVpp. Compared with controls, 
infection in the presence of heat-inactivated anti-
spike serum facilitated infection of human PBMCs 
with SARS-CoVpp (Fig 1). In order to shed light 
on the identity of the ADE-infected primary 
immune cells, co-staining for the widely accepted 
myeloid marker CD68 (macrosialin/gp110) was also 
performed. Among the cells infected in the presence 
of anti-viral antibodies, over 75% were positive for 
CD68 (Fig 1). Because CD68 was expressed on a 
variety of cells other than the monocytic lineage, 
we highly purified CD14+-cells (ie monocytes) and 
assessed their susceptibility to ADE of SARS-CoVpp 
infection.
The monocytic lineage is a prime target for 
ADE of SARS-CoV infection
As previously shown with the monocytic cell line 
THP-1,2 primary human monocytes were susceptible 
to infection by SARS-CoVpp in the presence of 
anti-spike antibodies only. Inoculums made of 
SARS-CoVpp, or SARS-CoVpp pre-incubated in 
the presence of control serum never resulted in a 
detectable luciferase signal (not shown). Because in 
the course of the deadly feline infectious peritonitis, 
anti-spike antibodies have been shown to trigger 
massive infection of macrophages, a key event for 
disease pathogenesis, we also monitored occurrence 
of antibody-mediated SARS-CoV infection in human 
monocyte-derived macrophages. When human 
macrophages were infected in the presence of anti-
spike immune-serum, detection of the luciferase 
reporter protein was markedly different compared 
with those infected in the presence of control 
serum (not shown). Of note, infection of primary 
macrophages with recombinant viral particles 
pseudotyped with the glycoprotein of the VSVpp or 
Δenv.pp was never modified by the presence of anti-
SARS-CoV spike immune serum (not shown). These 
experiments indicate that anti-spike antibodies 
facilitate infection of SARS-CoVpp but not VSVpp 
or Δenv.pp into human primary macrophages.
Antibody-mediated enhancement of SARS-
CoV infection in primary macrophages leads 
to abortive infection
Because of the well-established roles of the 
macrophages in the primary response to pathogens 
and in the shaping of the subsequent (pathogen-
specific) adaptive immune response, we investigated 
whether a change in tropism could also be observed 
during infection with replication-competent SARS-
CoV.
 Infection of monocyte-derived macrophages 
FIG 1.  Anti-spike immune serum triggers infection of human 
peripheral blood mononuclear cells with SARS-CoV spike 
pseudoparticles (SARS-CoVpp). SARS-CoVpp were incubated 
in the presence or absence of either control or anti-spike 
serum for 1 hour prior to addition to human peripheral blood 
mononuclear cells (PBMCs). Three days post-infection, samples 
were fixed with 2% paraformaldehyde and expression of 
CD68 (macrosialin/gp110) and firefly luciferase (SARS-CoV 
induced reporter gene) was revealed by immunostaining 
as described under material and methods. Cell nuclei were 
labelled with DAPI and quantification of the relative expression 
of two markers was done by counting positive events in 
five randomly chosen fields (400x final magnification), using 
Metamorph.
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by replication competent SARS-CoV in the presence 
of control serum led to modest infection. In contrast, 
when they were infected in the presence of anti-
spike immune-serum, intracellular detection of viral 
nucleocapsid protein was markedly increased (Fig 2). 
To assess the capability of SARS-CoV to productively 
replicate into ADE-infected macrophage cells, we 
monitored the cellular viral load with real-time 
quantitative RT-PCR as well as the release of SARS-
CoV progeny into cell culture supernatant.
 Quantitative measurements of either 
positive (ie genomic and mRNA) or negative (ie 
subgenomic replicative intermediates) RNA strands 
demonstrated a significant increased viral load at 6 
hours post-infection in cells infected in the presence 
of anti-spike serum, followed by a continuing 
decrease in both viral RNA species with time so that 
no difference between groups was noted later on (not 
shown). Of note, there was no evidence of spreading 
infection to other cells (not shown). Similarly we 
did not detect any change in viral gene copies when 
we assessed the viral yield of macrophage-infected 
supernatants, whether incubated in the presence or 
absence of immune serum. Altogether these results 
indicate that despite the ability of SARS-CoV to 
exploit anti-viral antibodies to invade macrophages, 
FIG 2.  Anti-spike antibodies enhanced SARS-CoV infection of human macrophages: Human monocyte-derived macrophages 
were infected (MOI=1) with SARS-CoV strain HK39849 (SCoV) in the presence of either control or anti-spike serum for 1 hour. 
Samples were fixed with 4% paraformaldehyde at 6 hours post-infection and stained with a mouse monoclonal antibody specific 
for the SCoV nucleocapsid (N) protein. Immunostaining was finally revealed with TRITC-conjugated goat anti-mouse and cell 
nuclei were labelled with DAPI. (a) Compared with control (1/1000 dilution control serum), detection of SCoV N viral protein 
was greatly increased when human macrophages (donor 1) were infected in the presence of anti-spike serum (1/1000 dilution). 
(b) Quantification of infection for each donor was done by counting positive cells in five randomly chosen fields (400x final 
magnification), using Metamorph (Reproduced with permission from the BioMed Central)
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only abortive replication occurs upon infection and 
no infectious virus is released from the ADE-infected 
cells.
ADE infection pathway does not alter the 
profile of cytokine/chemokine produced by 
primary human macrophages
The antibody-mediated entry route would affect 
functionality and cell homeostasis of ADE-infected 
macrophages but would not result in productive 
infection. Indeed, ADE infection induced the 
initiation of viral gene transcription, with production 
of viral gene intermediate species, and viral protein 
synthesis. Given the ability of intracellular innate 
immune sensors, such as the pattern recognition 
receptor families TLR and RLH, to detect viral gene 
species and the disturbance to the cell homeostasis 
caused by SARS-CoV viral proteins (such as 3a 
protein and SARS-Unique Domain), we evaluated 
the expression profile of some characteristic 
proinflammatory immune mediators and apoptosis-
inducing ligands. As previously documented, 
infection of human monocyte-derived macrophages 
with SARS-CoV led to induction of several pro-
inflammatory cytokines and chemokines, without 
expression of type-I interferon IFN-β (not shown). 
Similarly, infection in the presence of control serum 
did not trigger induction of IFN-β and similar 
kinetics and levels of TNF-α, CCL2/MCP-1, CCL3/
MIP-1α, and CXCL10/IP-10 were detected (Fig 3). 
When cells were infected in the presence of anti-
SARS-CoV spike immune-serum (Fig 3), despite 
a 3-4 fold increase in intracellular SARS-CoV viral 
load (Fig 2), no change in the kinetic or in the 
expression of the type-I interferons and the pro-
inflammatory cytokines/chemokines was noted. 
Similarly, compared with controls ADE-infection 
of macrophages never altered gene expression of 
prototypical death ligands such as TNF-α (Fig 3), 
FasL or TNF-related apoptosis-inducing ligand 
(not shown). Our results indicated that despite an 
enhanced infection of cells in the presence of anti-
viral antibodies, the occurrence of ADE of SARS-CoV 
entry had little effect on the inflammatory response 
and the death ligand-induced killing activity of the 
macrophages.
The occurrence of ADE of SARS-CoV 
infection relies on the intracellular signalling 
domain of the human FcγR by the target cells
Our previous work demonstrated a major role for 
immune receptors, particularly Fc-gamma receptor 
II (FcγRII) family, in triggering infection of immune 
cells with SARS-CoV.2 Because this FcR family 
includes members that bind immunoglogulins/
immune complexes with different affinities in addition 
to delivering either activating or inhibitory signals, 
we established a model to understand what, from 
binding event to the FcγRII or from internalisation/
signalling cascade, played a preponderant role in the 
occurrence of ADE infection. Thanks to molecular 
mutagenesis, we established immune cell lines 
that expressed either a truncated form (ie lacking 
intracellular domain) or chimeric form (ie swapping 
of the intracellular domain) of FcγRIIA (CD32a) and 
FcγRIIB (CD32b), the only two receptors proved to 
be involved in ADE of SARS-CoVpp.2 Our results 
indicated a prominent role of the intracellular 
domain over the extracellular domain of human 
FcγRII in the occurrence of ADE of SARS-CoVpp.3 
All the FcγRII receptors with truncation of their 
intracellular domain became unable to trigger 
ADE infection despite being able to efficiently 
bind immune complexes. This demonstrated that 
attachment of the immune-complexes to the target 
cells was not an event sufficient to trigger ADE of 
SARS-CoVpp infection (not shown). 
Discussion
The possibility that an immune response to 
pathogens may also have deleterious effects on the 
host homeostasis has been reported. For example, 
the hyper-induction of cytokines following avian 
influenza infection has been implicated in the 
severity of the disease, and infection of cells by 
antibody-dependent enhancement has been known 
to occur for several viral diseases.1 In our study, 
anti-spike antibody potentiated infection of primary 
human immune cells with SARS spike-pseudotyped 
lentiviral particles and replication-competent SARS-
coronavirus. Nonetheless in macrophages, antibody-
mediated infection did not lead to productive 
replication of the virus, and did not induce a 
skewed profile of proinflammatory cytokines and 
chemokines.
 After initiation of viral gene transcription and 
viral protein synthesis, a block seems to occur in the 
replication process ultimately ending in an abortive 
viral cycle without detectable release of progeny 
virus. Such abortive replication of SARS-CoV into 
macrophages has been documented,4 but conversely 
to this previous report where 90% of the macrophages 
were infected with SARS-CoV in the absence of 
immune-serum (MOI=1-2). We detected a much 
lower infection yield (about 5-7%) using a similar 
experimental setup. Of note from three independent 
donors, two macrophage cultures showed evident 
infection (≥5% infected macrophages; donor 1 and 
2), whereas one displayed low permissiveness (<1% 
infected macrophages; donor 3) [Fig 2]. In the latter, 
addition of anti-spike antibodies did not make the 
macrophages more susceptible to infection, thus 
likely illustrating inter-individual variability of 
human macrophage to SARS-CoV infection.
 Despite a four-fold increase in infection 
and initiation of viral gene transcription in the 
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FIG 3.  Induction of cytokines/chemokines by SARS-CoV in human macrophages following antibody-mediated infection: Human monocyte-derived 
macrophages were incubated for 1 hour in the absence or presence of SARS-CoV strain HK39849 (SCoV), with two-fold serial dilutions (1/1000 and 
1/2000) of either control (open bars) or anti-spike (closed black bars) serum. Cells were lysed at 1, 6, 24, and 72 hours post-infection, and total RNAs 
were extracted for RT-PCR amplification. The mRNA levels of different cytokines and chemokines were determined by real-time quantitative RT-PCR 
and for the sake of clarity only one serum dilution (1/1000) is shown. In most cases, when induced, cytokines/chemokines were detected before 24 hours 
post-infection only. Addition of anti-spike serum, compared with control serum, did not lead to a skewed expression profile and no significant changes were 
seen (Reproduced with permission from the BioMed Central)
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ADE-infected macrophages, no change in gene 
expression of some pro-inflammatory cytokines/
chemokines and death ligands was detected. 
Although we did not thoroughly investigate the 
occurrence of cell death with dedicated methods, 
our microscopic observations did not reveal 
chromatin condensation or membrane blebbing 
of the ADE-infected macrophages up to 72 hours 
post infection. Considering approximately 20% of 
macrophages were ADE-infected, and in regard to 
the apparent well-being of the infected cultures with 
cell loss/variation in total cell number of less than 
8% throughout the 3-day assay, we speculate that in 
macrophages, ADE of SARS-CoV infection does not 
trigger massive cell death.
 In regard to clinical observations of poor 
disease outcomes in early seroconverted SARS 
patients,5 and because ADE of other viral infections 
(such as Ross River Virus, feline coronavirus, 
poliovirus, coxsackievirus) have been shown to 
elicit markedly distinct responses compared with 
viral entry through the natural host receptor, and 
as immune deregulation is a hallmark of SARS, 
involvement of ADE mechanisms during SARS 
pathogenesis was worthy of investigation.
 The findings of this study partially invalidated 
our initial hypothesis that antibody-mediation 
would, by widening tropism of SARS-CoV 
toward immune cells, elicit an altered profile of 
immune mediators that impair homeostasis of the 
immune system and ultimately contribute to SARS 
pathogenesis. Nonetheless, it is still intriguing to us 
that triggering an enhanced infection of cornerstone 
innate immune cells such as macrophages would 
have no consequences. It is true that in contrast 
to studies that showed cell perturbation following 
ADE-infection, others have documented fewer, 
barely discernible consequences.6 Hence it is 
possible that ADE of SARS-CoV infection is 
happening without deleterious consequences to 
the target cells. Nonetheless, with reference to the 
great deal of controversy in the literature regarding 
the relationship between immune mediators, cell 
death and the pathophysiological events of SARS, 
our study may not have focused on the right gene 
candidates. Thus for future investigations, it is 
advised to conduct genome-wide gene expression 
profiling.
Conclusion
Our results suggest the rational development of 
vaccination strategies in the event of a SARS-like 
virus outbreak, with reasonable concerns about the 
occurrence of severe adverse effects.
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